SYNTHESIS OF DEUTERIUM-LABELED PYRROLYLCARNOSINE

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The effect of temperature on the effectiveness of the introduction of deuterium into pyrrolylcarnosine (PC) has been studied. Deuterium gas and heavy water were used as a source of deuterium. Isotope exchange was carried out using solid-phase and liquid-phase methods. It was found that it is better to use isotope exchange with deuterated water to obtain preparative amounts of labeled pyrrolylcarnosine. When using the solid-phase method, the main label is in pyrrole. The inclusion of deuterium at a higher temperature occurs more evenly. In addition, the use of deuterated water made it possible to reduce the amount of unlabeled isotopomer to almost 0%, obtain a product with a yield of 70% and a content of more than 7 deuterium atoms. It is established that the content of deuterium in the substance can be increased by pretreating the reaction mixture with deuterium gas. This approach opens up additional opportunities for synthesis of labeled compounds.

Sobre autores

V. Shevchenko

Institute of Molecular Genetics of National Research Centre “Kurchatov Institute” (NRC “Kurchatov Institute” – IMG); Institute of Molecular Genetics of National Research Centre “Kurchatov Institute” (NRC “Kurchatov Institute” – IMG)

Autor responsável pela correspondência
Email: nagaev@img.ras.ru
Russian Federation, 123182, Moscow; Russian Federation, 123182, Moscow

I. Nagaev

Institute of Molecular Genetics of National Research Centre “Kurchatov Institute” (NRC “Kurchatov Institute” – IMG)

Email: nagaev@img.ras.ru
Russian Federation, 123182, Moscow

T. Fedorova

Research Center of Neurology (RCN)

Email: nagaev@img.ras.ru
Russian Federation, 125367, Moscow

N. Myasoedov

Institute of Molecular Genetics of National Research Centre “Kurchatov Institute” (NRC “Kurchatov Institute” – IMG)

Email: nagaev@img.ras.ru
Russian Federation, 123182, Moscow

Bibliografia

  1. Федорова Т.Н., Стволинский С.Л., Мигулин В.А., Лопачев А.В., Хуторова А.В., Куликова О.И., Музычук О.А., Абаимов Д.А. Патент № 2777391, 03.08.2022, Бюл. № 22.
  2. Boldyrev A., Fedorova T., Stepanova M., Dobrotvorskaya I., Kozlova E., Boldanova N., Bagyeva G., Ivanova-Smolenskaya I., Illarioshkin S. // Rejuvenation Res. 2008. Vol. 11. № 4. P. 821–827.
  3. Kulikova O.I., Stvolinsky S.L., Migulin V.A., Andreeva L.A., Nagaev I.Yu., Lopacheva O.M., Kulichenkova K.N., Lopachev A.V., Trubitsina I.E., Fedorova T.N. // Daru. 2020. Vol. 28. P. 119–130.
  4. Adams S.P., Tsang M., Wright J.M. // Cochrane Database Syst. Rev. 2015.
  5. Bhardwaj V., Gumber D., Abbot V., Dhiman S., Sharma P. // RSC Adv. 2015. Vol. 5. № 20. P. 15233–15266.
  6. Каратеев А.Е. // Современная ревматология. 2014. Т. 8. № 2. С. 83–89.
  7. Toth G., Mallareddy J.R., Toth F., Lipkowski A.W., Tourwe D. // Arkivoc. 2012. Vol. 2012. № 5. P. 163–174.
  8. Rees A.T. // J. Labelled Compd. Radiopharm. 2004. Vol. 47. № 5. P. 318–319.
  9. Voges R., Heys J.R., Moenius T. “Preparation of Compounds Labeled with Tritium and Carbon-14” United Kingdom: John Wiley & Sons. Ltd. 2009. 664 p.
  10. Stack D.E., Eastman R. // J. Label. Compd. Radiopharm. 2016. Vol. 59. № 12. P. 500–505.
  11. Lockley W.J.S., Hesk D. // J. Label. Compd. Radiopharm. 2010. Vol. 53. № 11–12. P. 704–715.
  12. Lockley W.J.S. // Tetrahedron Lett. 1982. Vol. 23. № 37. P. 3819–3822.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
2.

Baixar (12KB)
3.

Baixar (69KB)
4.

Baixar (51KB)

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies